Why the study?
Does noradrenaline affect coronary resistance in isolated perfused hearts?
Does noradrenaline affect coronary resistance in isolated perfused hearts?
The direct action of noradrenaline on coronary vessels is vasoconstriction, with vasodilation occurring secondary to myocardial stimulation at higher concentrations.
Answers are grounded in this paper and cite their sources.
Noradrenaline's direct vasoconstriction in isolated hearts should not yet guide clinical use; leaves open translation to intact human physiology.
The effects of “physiological” concentrations of noradrenaline on the coronary resistance of isolated, perfused hearts of the cat, dog and monkey were determined. At the lowest active concentrations of noradrenaline (2–4 ng/ml), the preparations always responded with an increase in coronary resistance associated with an un-recordable or minimal myocardial response. As the concentration increased, the effect of the amine on the coronary resistance became biphasic. There was an initial transient increase followed by a more prolonged decrease in resistance associated with a significant myocardial response. These results support other evidence that the direct action of noradrenaline on the coronary vessels is one of vasoconstriction, and that the decrease in resistance associated with larger concentrations of noradrenaline is secondary to the myocardial stimulation, perhaps by way of vasodilating metabolites. Lack of agreement of results may well arise due to the use of concentrations of noradrenaline which also affect the myocardium.
No takes yet. Share an insight, caveat, or question.
E. Proctor (1968) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: